The Wnt & β-Catenin Targeted Drug Discovery Summit is the only meeting uniting leading pharma, pioneering biotechs and reputed academics under a mutual and ambitious objective of accelerating your novel Wnt/β-catenin candidates into clinic and market.

Built with Leap Therapeutics, Fog Pharma, Surrozen, Iterion Therapeutics, Genentech, and other leading companies, the summit will allow you to gain knowledge on the inhibition and activation of the Wnt pathway. You can be sure to take away practical insights and actionable strategies on how to harness this previously undruggable target.

With 24+ expert speakers, this is your definitive opportunity to be a part of this exciting and growing community, and this dedicated virtual summit will ensure you get your answers to your questions.

To find out more and view the 2021 speaker line-up, download the full event guide.

5 unmissable keynotes include:

• Supercharging Your Wnt/β-catenin Clinical Program by Surrozen, Iterion Therapeutics, AntlarA & Leap Therapeutics
• Getting a Grip on Wnt Biology to Theorize the Latest Opportunities & Understandings with Iterion Therapeutics, Genentech & Auburn University
• Opportunities to Aid Drug Discovery & Further Research Efforts with Biovista & the DTRF
• Delving into Immuno-Oncology to Further Oncological Treatment Efficacy, brought to you by UAB, Duke Cancer Institute & Shandong First Medical University
• Harnessing Novel Pathways Approach to Drive Preclinical Insights delivered by
  Fog Pharma, RedX Pharma & The University of Oxford

To know more about the Wnt & β-Catenin Targeted Drug Discovery Summit please click here.